<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03591588</url>
  </required_header>
  <id_info>
    <org_study_id>H21418</org_study_id>
    <nct_id>NCT03591588</nct_id>
  </id_info>
  <brief_title>Effects of Diet Interventions on Monocytes in Metabolic Syndrome</brief_title>
  <official_title>Effects of Diet Interventions on Monocyte Phenotypes in Individuals With Metabolic Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baylor College of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baylor College of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Subjects with hypertriglyceridemia and metabolic syndrome are being recruited and receive
      diet interventions with either a high-saturated fat diet or a low-fat high protein diet for 4
      days (days 1-4) and a breakfast on day 5. Blood samples are collected on day 1 and day 5 to
      examine lipid levels and circulating monocyte phenotypes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects with hypertriglyceridemia and metabolic syndrome are being recruited and receive
      diet interventions with either a high-saturated fat diet or a low-fat high protein diet for 4
      days (days 1-4) and a breakfast on day 5. Blood samples are collected on day 1 at fasting
      state and on day 5 at fasting state and 4 and 6 hours after the breakfast to examine lipid
      levels and circulating monocyte phenotypes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2016</start_date>
  <completion_date type="Actual">March 31, 2020</completion_date>
  <primary_completion_date type="Actual">March 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>The study includes 2 types of diets, i.e., high-saturated fat diet and low-fat high-protein diet, in the same individuals with randomized crossover design.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effects of diet interventions on monocyte phenotypes</measure>
    <time_frame>2016 to 2020</time_frame>
    <description>Monocyte phenotypes</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Metabolic Syndrome</condition>
  <condition>Hypertriglyceridemia</condition>
  <arm_group>
    <arm_group_label>high-saturated fat diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Diet high in saturated fat (~50% calorie from fat, ~25% from saturated fat)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>low-fat diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Diet with low fat (~25% calorie from fat)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>diet</intervention_name>
    <description>The study includes 2 types of diets, i.e., high-saturated fat diet and low-fat high-protein diet, which are provided to each participant in a randomized crossover design.</description>
    <arm_group_label>high-saturated fat diet</arm_group_label>
    <arm_group_label>low-fat diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Obese women and men with metabolic syndrome (MS)

          -  Fasting triglyceride (TG) equal to or greater than 150 mg/dl

        Exclusion Criteria:

          -  &lt;21 years of age

          -  Perimenopausal, pregnant or breastfeeding women

          -  Current smokers

          -  Obvious inflammation or other acute illnesses

          -  Obesity due to endocrinologic disorders including polycystic ovary syndrome

          -  Partial lipodystrophy

          -  Diabetes requiring insulin or &gt;1 oral medication

          -  Fasting TG â‰¥650 mg/dl

          -  A history of pancreatitis

          -  Myocardial infarction within the past 3 years

          -  Any hospitalization within the past 2 months

          -  Takes steroids.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>HUAIZHU WU, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baylor College of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Center for Prevention of cardiometabolic disease</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 9, 2018</study_first_submitted>
  <study_first_submitted_qc>July 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2018</study_first_posted>
  <last_update_submitted>July 7, 2020</last_update_submitted>
  <last_update_submitted_qc>July 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Baylor College of Medicine</investigator_affiliation>
    <investigator_full_name>Huaizhu Wu</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Hypertriglyceridemia</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

